For the year ending 2025-12-31, BVS has $683,559K in assets. $455,112K in debts. $51,238K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 51,238 | |||
| Accounts receivable, net | 128,303 | |||
| Inventory | 82,236 | |||
| Prepaid and other current assets | 11,065 | |||
| Total current assets | 272,842 | |||
| Property and equipment, net | 21,899 | |||
| Goodwill | 7,462 | |||
| Intangible assets, net | 368,419 | |||
| Operating lease assets | 5,122 | |||
| Deferred tax assets | 5,522 | |||
| Investment and other assets | 2,293 | |||
| Total assets | 683,559 | |||
| Accounts payable | 10,928 | |||
| Accrued liabilities | 130,242 | |||
| Current portion of long-term debt | 15,000 | |||
| Current portion of contingent consideration | 0 | |||
| Other current liabilities | 4,210 | |||
| Total current liabilities | 160,380 | |||
| Long-term debt, less current portion | 278,951 | |||
| Deferred income tax liabilities | 433 | |||
| Other long-term liabilities | 15,348 | |||
| Total liabilities | 455,112 | |||
| Common stock, value-Common Class A | 67 | |||
| Common stock, value-Common Class B | 16 | |||
| Additional paid-in capital | 520,851 | |||
| Accumulated deficit | -334,929 | |||
| Accumulated other comprehensive loss | -1,900 | |||
| Total stockholders equity attributable to bioventus inc | 184,105 | |||
| Noncontrolling interest | 44,342 | |||
| Total stockholders equity | 228,447 | |||
| Total liabilities and stockholders equity | 683,559 | |||
Bioventus Inc. (BVS)
Bioventus Inc. (BVS)